• Home
  • Newsroom
  • News Releases
  • 'Stand Up To Cancer' to feature Dana-Farber/Children's Hospital Cancer Center patient in national broadcast

'Stand Up To Cancer' to feature Dana-Farber/Children's Hospital Cancer Center patient in national broadcast


Building on its historic fundraising telecasts in 2008 and 2010, Stand Up To Cancer (SU2C) will return to primetime television on Friday, September 7 (8:00 pm, ET). The program, which will feature performances from top recording artists, and celebrities from film, television and sports, will encourage viewers to provide financial support for translational research aimed at accelerating the delivery of new cancer therapies to patients.

ABC, CBS, FOX and NBC are donating one hour of simultaneous commercial-free primetime for the nationally televised fundraising special. A number of cable outlets will air the program as well.

This year's program is expected to include a taped segment featuring Avalanna Routh, a Dana-Farber/Children's Hospital Cancer Center patient who is being treated for atypical teratoid rhabdoid tumor (ATRT), her doctor, Susan Chi, MD, and Charles Roberts, MD, PhD, whose laboratory is researching ATRT. Roberts also is one of five Dana-Farber affiliated researchers whose work is being supported with a SU2C Innovative Research Grant, which provides each recipient with up to $750,000 of funding over three years. The other Dana-Farber investigators are Catherine Wu, MD, Kimberly Stegmaier, MD, Loren Walensky, MD, PhD, and David Weinstock, MD.

Dr. Charles Roberts and Dr. Susan Chi will be in a featured segment on the SU2C broadcast Friday, September 7th at 8:00 pm.Dr. Charles Roberts and Dr. Susan Chi will be in a featured segment on the SU2C broadcast Friday, September 7th at 8:00 pm. 

"Stand Up To Cancer demonstrates the power of the entertainment community to help unite the public in support of a crucial cause that affects us all," said SU2C Executive Leadership Council Member Sherry Lansing, who is also the board chair of the Entertainment Industry Foundation, which helped found SU2C and is producing the broadcast program.

To date, more than $180 million has been pledged for SU2C's innovative cancer research. Since 2008, SU2C has made grants to seven multi-disciplinary "Dream Teams" of researchers, which include 14 Dana-Farber clinicians and researchers:

Prostate Cancer Dream Team

Philip Kantoff, MD
Levi Garraway, MD, PhD

PI3K Dream Team

Thomas Roberts, PhD
J. Dirk Iglehart, MD
David Livingston, MD
Ursula Matulonis, MD
Andrea Richardson, MD, PhD
Eric Winer, MD

CTC-Chip Dream Team

Bruce Johnson, MD
Charles Fuchs, MD
Judy Garber, MD
William Hahn, MD, PhD
Pasi Jänne, MD, PhD
Ian Krop, MD, PhD

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms
  • Media Contacts

    • For all inquiries, call 617-632-4090 and ask to speak to a member of the media team. Please direct emails to media@dfci.harvard.edu.